mibefradil has been researched along with Cardiac Output, Low in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carayon, A; Crozatier, B; Hittinger, L; Renaud, N; Su, J | 1 |
| Clozel, JP; Compagnon, P; Henry, JP; Koen, R; Lallemand, F; Macé, B; Mulder, P; Richard, V; Thuillez, C | 1 |
2 other study(ies) available for mibefradil and Cardiac Output, Low
| Article | Year |
|---|---|
Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.
Topics: Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Diltiazem; Dogs; Heart Rate; Hemodynamics; Mibefradil; Nitroprusside; Norepinephrine; Sympathetic Nervous System; Tetrahydronaphthalenes; Ventricular Dysfunction, Left | 1994 |
Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Cardiac Output, Low; Catecholamines; Hemodynamics; Male; Mibefradil; Rats; Rats, Wistar; Renin; Tetrahydronaphthalenes; Treatment Outcome | 1997 |